Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F64W8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,806
Award facts
- Contract value 100% obligated
- $12,806.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on January 5, 2026, with an ultimate completion date of January 6, 2026. The contract, valued at $12,806.05, covers the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune and inflammatory conditions. The award was made on a competitive basis with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and active through December 2026, which authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp fulfills critical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains through the DLA's Medical Supply Chain. This delivery order represents a routine transaction under the company's established prime IDC, enabling continued pharmaceutical support for military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F64W8?
SPE2DR26F64W8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F64W8 worth?
The government has obligated $12,806 on SPE2DR26F64W8.
Is contract SPE2DR26F64W8 an order under another contract?
Yes. SPE2DR26F64W8 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F64W8 competed?
The extent of competition for SPE2DR26F64W8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award